Exhibit 25.1
FORM T-1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Washington, D.C. 20549
STATEMENT OF ELIGIBILITY
UNDER THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE
UNDER THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE
CHECK IF AN APPLICATION TO DETERMINE
ELIGIBILITY OF A TRUSTEE PURSUANT TO
SECTION 305(b)(2)o
ELIGIBILITY OF A TRUSTEE PURSUANT TO
SECTION 305(b)(2)o
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
(Exact name of trustee as specified in its charter)
95-3571558 | ||
(State of incorporation | (I.R.S. employer | |
if not a U.S. national bank) | identification no.) | |
700 South Flower Street | ||
Suite 500 | ||
Los Angeles, California | 90017 | |
(Address of principal executive offices) | (Zip code) |
ArvinMeritor, Inc.
(Exact name of obligor as specified in its charter)
Indiana | 38-3354643 | |
(State or other jurisdiction of | (I.R.S. employer | |
incorporation or organization) | identification no.) |
TABLE OF ADDITIONAL REGISTRANTS
Jurisdiction of | I.R.S. Employer | |||
Incorporation or | Identification | |||
Name of Additional Registrant | Organization | Number | ||
Arvin Cayman Islands, Ltd | Cayman Islands | 98-0338029 | ||
Arvin European Holdings (UK) Limited | United Kingdom | 38-3559691 | ||
Arvin Holdings Netherlands B.V | Netherlands | 98-0589784 | ||
Arvin Innovation Holdings, Inc | Delaware | 26-4240411 | ||
Arvin Innovation Management, Inc | Delaware | 25-1221513 | ||
Arvin Innovation Mexico Holdings II, LLC | Delaware | 26-3131998 | ||
Arvin Innovation Mexico Holdings III, LLC | Delaware | 26-3790510 | ||
Arvin Industries Foreign Sales Corporation | Virgin Islands of the United States | 66-0417358 | ||
Arvin International Holdings, LLC | Delaware | 90-0218822 | ||
Arvin Replacement Products Finance, LLC | Delaware | 38-3617890 | ||
Arvin Technologies, Inc | Michigan | 38-3349979 | ||
ArvinMeritor Assembly, LLC | Delaware | 38-3617889 | ||
ArvinMeritor Brake Holdings, Inc | Delaware | 25-1251994 | ||
ArvinMeritor B.V | Netherlands | 52-2196515 | ||
ArvinMeritor Filters Holding Co., LLC | Delaware | 38-2060287 | ||
ArvinMeritor Filters Operating Co., LLC | Delaware | 73-1305936 | ||
ArvinMeritor Former Ride Control Operating Co., Inc | Delaware | 36-3739286 | ||
ArvinMeritor Holdings, LLC | Delaware | 74-3189806 | ||
ArvinMeritor Holdings Mexico, LLC | Delaware | 98-0439989 | ||
ArvinMeritor, Inc., a Nevada Corporation | Nevada | 52-2092391 | ||
ArvinMeritor Investments, LLC | Delaware | 98-0216621 | ||
ArvinMeritor Limited | United Kingdom | 98-0110847 | ||
ArvinMeritor Mascot, LLC | Delaware | 26-2497100 | ||
ArvinMeritor OE, LLC | Delaware | 38-3622443 | ||
Arvinmeritor Sweden AB | Sweden | 98-0473144 | ||
ArvinMeritor Technology, LLC | Delaware | 52-2196523 | ||
Arvinyl West, Inc | California | 95-1934716 | ||
AVM, Inc | South Carolina | 36-3739285 | ||
Euclid Industries, LLC | Delaware | 38-3442143 | ||
Gabriel Europe, Inc | Delaware | 36-2809524 | ||
Maremont Corporation | Delaware | 13-2986138 | ||
Maremont Exhaust Products, Inc | Delaware | 36-3739284 | ||
Meritor Cayman Islands, Ltd | Cayman Islands | 38-3559688 | ||
Meritor Heavy Vehicle Braking Systems (U.S.A.), Inc | Delaware | 38-3441039 | ||
Meritor Heavy Vehicle Systems, LLC | Delaware | 38-3371768 | ||
Meritor Heavy Vehicle Systems (Mexico), Inc | Delaware | 38-3436042 | ||
Meritor Heavy Vehicle Systems (Singapore) Pte., Ltd | Delaware | 25-1407192 | ||
Meritor Heavy Vehicle Systems (Venezuela), Inc | Delaware | 38-3436040 | ||
Meritor Holdings Netherlands B.V | Netherlands | 98-0218743 | ||
Meritor Light Vehicle Systems (Spain), Inc | Delaware | 52-2092227 | ||
Meritor Luxembourg S.A.R.L | Luxembourg | 98-0217915 | ||
Meritor Management, Inc | Delaware | 26-3151995 | ||
Meritor Technology, Inc | Delaware | 98-0272396 | ||
Meritor Transmission Corporation | Delaware | 38-3481985 |
-2-
2135 West Maple Road | ||
Troy, Michigan | 48084-7186 | |
(Address of principal executive offices) | (Zip code) | |
Debt Securities
(Title of the indenture securities)
(Title of the indenture securities)
-3-
1. | General information. Furnish the following information as to the trustee: |
(a) | Name and address of each examining or supervising authority to which it is subject. |
Name | Address | |
Comptroller of the Currency United States Department of the Treasury | Washington, D.C. 20219 | |
Federal Reserve Bank | San Francisco, California 94105 | |
Federal Deposit Insurance Corporation | Washington, D.C. 20429 |
(b) | Whether it is authorized to exercise corporate trust powers. |
Yes.
2. | Affiliations with Obligor. | |
If the obligor is an affiliate of the trustee, describe each such affiliation. | ||
None. |
16. | List of Exhibits. | |
Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto, pursuant to Rule 7a-29 under the Trust Indenture Act of 1939 (the “Act”) and 17 C.F.R. 229.10(d). |
1. | A copy of the articles of association of The Bank of New York Mellon Trust Company, N.A., formerly known as The Bank of New York Trust Company, N.A. (Exhibit 1 to Form T-1 filed with Registration Statement No. 333-121948 and Exhibit 1 to Form T-1 filed with Registration Statement No. 333-152875). | ||
2. | A copy of certificate of authority of the trustee to commence business. (Exhibit 2 to Form T-1 filed with Registration Statement No. 333-121948). | ||
3. | A copy of the authorization of the trustee to exercise corporate trust powers (Exhibit 3 to Form T-1 filed with Registration Statement No. 333-152875). |
- 4 -
4. | A copy of the existing by-laws of the trustee (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-162713). | ||
6. | The consent of the trustee required by Section 321(b) of the Act (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-152875). | ||
7. | A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining authority. |
- 5 -
SIGNATURE
Pursuant to the requirements of the Act, the trustee, The Bank of New York Mellon Trust Company, N.A., a banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of Chicago, and State of Illinois, on the 13th day of November, 2009.
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. | ||||
By: | /S/ D. G. DONOVAN | |||
Name: | D. G. DONOVAN | |||
Title: | VICE PRESIDENT | |||
- 6 -
EXHIBIT 7
Consolidated Report of Condition of
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
of 700 South Flower Street, Suite 200, Los Angeles, CA 90017
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
of 700 South Flower Street, Suite 200, Los Angeles, CA 90017
At the close of business September 30, 2009, published in accordance with Federal regulatory authority instructions.
Dollar Amounts | ||||
in Thousands | ||||
ASSETS | ||||
Cash and balances due from depository institutions: | ||||
Noninterest-bearing balances and currency and coin | 1,585 | |||
Interest-bearing balances | 426 | |||
Securities: | ||||
Held-to-maturity securities | 16 | |||
Available-for-sale securities | 553,806 | |||
Federal funds sold and securities purchased under agreements to resell: | ||||
Federal funds sold | 83,000 | |||
Securities purchased under agreements to resell | 0 | |||
Loans and lease financing receivables: | ||||
Loans and leases held for sale | 0 | |||
Loans and leases, net of unearned income | 0 | |||
LESS: Allowance for loan and lease losses | 0 | |||
Loans and leases, net of unearned income and allowance | 0 | |||
Trading assets | 0 | |||
Premises and fixed assets (including capitalized leases) | 10,983 | |||
Other real estate owned | 0 | |||
Investments in unconsolidated subsidiaries and associated companies | 1 | |||
Direct and indirect investments in real estate ventures | 0 | |||
Intangible assets: | ||||
Goodwill | 852,858 | |||
Other intangible assets | 251,145 | |||
Other assets | 156,398 | |||
Total assets | $ | 1,910,218 | ||
- 7 -
Dollar Amounts | ||||
in Thousands | ||||
LIABILITIES | ||||
Deposits: | ||||
In domestic offices | 1,712 | |||
Noninterest-bearing | 1,712 | |||
Interest-bearing | 0 | |||
Not applicable | ||||
Federal funds purchased and securities sold under agreements to repurchase: | ||||
Federal funds purchased | 0 | |||
Securities sold under agreements to repurchase | 0 | |||
Trading liabilities | 0 | |||
Other borrowed money: | ||||
(includes mortgage indebtedness and obligations under capitalized leases) | 268,691 | |||
Not applicable | ||||
Not applicable | ||||
Subordinated notes and debentures | 0 | |||
Other liabilities | 198,124 | |||
Total liabilities | 468,527 | |||
Not Applicable | ||||
EQUITY CAPITAL | ||||
Perpetual preferred stock and related surplus | 0 | |||
Common stock | 1,000 | |||
Surplus (exclude all surplus related to preferred stock) | 1,121,520 | |||
Not Applicable | ||||
Retained earnings | 316,907 | |||
Accumulated other comprehensive income | 2,264 | |||
Other equity capital components | 0 | |||
Not Available | ||||
Total bank equity capital | 1,441,691 | |||
Noncontrolling (minority) interests in consolidated subsidiaries | 0 | |||
Total equity capital | 1,441,691 | |||
Total liabilities and equity capital | 1,910,218 | |||
I, Karen Bayz, Managing Director of the above-named bank do hereby declare that the Reports of Condition and Income (including the supporting schedules) for this report date have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true to the best of my knowledge and belief.
Karen Bayz ) Managing Director
We, the undersigned directors (trustees), attest to the correctness of the Report of Condition (including the supporting schedules) for this report date and declare that it has been examined by us and to the best of our knowledge and belief has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true and correct.
Troy Kilpatrick, MD | ) | |||||||
Frank P. Sulzberger, MD | ) | Directors (Trustees) | ||||||
William D. Lindelof, MD | ) |
- 8 -